Lv2
130 积分 2024-12-17 加入
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
7小时前
待确认
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
14天前
已完结
The Biomarkers Consortium: 20 years of advancing precision medicine
14天前
已完结
Evolutionary Overview and Future Perspectives: ESR1 Mutations, Liquid Biopsy, and Artificial Intelligence for a New Era of Personalized Medicine in ER+ Breast Cancer
28天前
已完结
Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes
4个月前
已完结
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer
4个月前
已完结
Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally Metastatic Prostate Cancer
4个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
5个月前
已完结
Targeting DNA damage in ageing: towards supercharging DNA repair
5个月前
已完结
The non-small-cell lung cancer drug market
5个月前
已完结
皖公网安备34019202002308
